SK Biopharmaceuticals Co., Ltd. (KRX: 326030)
South Korea
· Delayed Price · Currency is KRW 103,600
-2,700 (-2.54%)
Dec 19, 2024, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.00 trillion as of December 20, 2024. Its market cap has increased by 18.31% in one year.
Market Cap
8.00T
Enterprise Value
7.93T
Revenue
511.33B
Ranking
n/a
PE Ratio
139.34
Stock Price
103,600.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.00T, a decrease of -19.61%. That is a compound annual growth rate of -4.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 7,995.78B | 1.69% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition